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Table 1
Patient's demographic data
Global Method 1 Method 2 P
Total (n) 26 13 13
Transplant (n) .43
Autologous 12 5 7
Allogeneic 14 8 6
Receptor age (years) .75
Median (range) 26 (3-56) 27 (5-55) 25 (3-56)
Table 2
Overall results in the study
Global Rubinstein's New Method P
Abstracts / Biol Blood Marrow Transplant 19 (2013) S342eS354S350Rubinstein in 1995 (method 1). Ours (method 2) pretend to
increase more than 10 fold the dilution of cryopreserved
HSCs in the standardwashing solution (5% albumin + dextran
40). Methods 1 and 2 were compared to determine viability
by means of total-nucleated-cell (TNC) count by trypan blue
and ﬂow cytometry at the time of collection, cryopreserva-
tion, thawing, and after removing the DMSO, as well as the
patient's day of engraftment.
Results: Results are shown in Tables 1 and 2.
Conclusions: A greater dilution of cryopreserved HSCs in the
washing solution, as a new thawing method, may decrease
cell death; therefore a greater number of HSCs will be
infused to the patient. Studies with a larger number of
thawing procedures are needed to make this assertion.Figure 1. Viability loss
Figure 2. Neutrophil engrafment
Figure 3. Platelel engrafmentMethod
Viability before
thawing.
Mean (SD)
97.28% (6.55) 99.01% (1.08) 95.56% (9.04) .30
Viability after
thawing.
Mean (SD)
78.92% (11.69) 75.46% (12.5) 82.39% (10.12) .15
Viability loss.
Mean (SD)
18.36% (12.11) 23.55% (12.74) 13.18% (9.21) .02
Engrafment days
>20,000
Platelets.
Median (range)
11 (6-23) 11 (6-23) 11 (7-19) .60
Engrafment
days >500
Neutrophils.
Median (range)
13.5 (6-28) 13 (6-28) 14 (9-17) .30483
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Multipotent adult progenitor cells (MAPC; Multistem) are
adult adherent stromal stem cells currently being assessed
in acute GVHD clinical trials with demonstrated immuno-
modulatory capabilities and the potential to ameliorate
detrimental autoimmune and inﬂammation-related
processes. Our previous studies documented that MAPC
secrete factors that play a role in regulating T cell activity.
Here we expand our studies using a proteomics approach to
characterize and quantify MAPC secretome components
secreted over 72 hours in vitro under steady-state condi-
tions and in the presence of inﬂammatory triggers IFN-
gamma and LPS, or a tolerogenic CD74 ligand, RTL1000.
MAPC differentially respond to each of the tested stimuli,
secreting molecules that regulate the biological activity of
the extra-cellular matrix (ECM), including proteins that
comprise the ECM itself, proteins that regulate its
construction/de-construction, and proteins that serve to
attach and de-attach growth factors from ECM components
for redistribution upon appropriate stimulation. MAPC
secrete a wide array of proteases, some detectable in their
zymogen forms, as well as protease inhibitors that serve to
poise the ECM in a state of repose, ready to respond
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quential to local physical injury to tissue or inﬁltration by
various cell types. MAPC also secrete chemokines and
cytokines that could provide molecular guidance cues to
various cell types including neutrophils, macrophages and T
cells, as well as secrete factors known to be involved in
maintenance of a homeostatic environment and regulating
such diverse programs as innate immunity, angiogenesis/
angiostasis, targeted delivery of growth factors, and the
matrix-metalloprotease cascade.POSTER SESSION 2: TRANSPLANT
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Background: Five geographically distant Hem-BMT
programs came together to form the Sarah Cannon Blood
Cancer Network (SCBCN) in 2011. The programs are FACT
accredited with a Network volume of about 750 transplants
per year. Each program had diverse methods of demon-
strating and documenting competency and providing staff
education.
Objectives:
1. Advance quality by standardizing core competency
and education content through harnessing the exper-
tise in each program.
2. Leverage the network approach to create a signiﬁcant
education resource gain for each program.
Interventions: A multidisciplinary, multi-institutional work
group was created with the goal of standardizing profes-
sional education across the SCBCN to include initial and
annual competencies and clinical education. This workgroup
was divided into discipline-based sub-groups (Nursing,
Pharmacy, Mid-Level Practitioners and Physicians) that were
charged with creating discipline-speciﬁc competencies
based on FACT and professional organization standards. The
intent was to create core competencies that could be
expanded but not reduced.
Results:
1. Comprehensive core initial competency grids with
Learning Options tool completed for Nursing, Mid-
Level Practitioners, and Pharmacists across the SCBCN.
2. Standardized annual competencies for 2013 created for
Nursing, Mid-Level Practitioners, Pharmacists and
Physicians. Competencies and credentialing require-
ments were developed using FACT requirements and
SCBCN Programs needs assessment data.3. Six comprehensive educationmodules in development
across the network using SCBCN nursing and phar-
macy experts to be implemented for 2013 staff
education via Healthstream (an electronic education
program which includes documentation of compli-
ance). Idea generation for modules came from the
network clinical experts who created the draft content
with network feedback.485
What Tools are in Your Toolbox to Promote Change?
Barbara Ann Cuccovia 1, Leslie Lehmann 2, Steven Margossian 3,
Stephanie Buia-Amport 1, Christine Rosati 4. 1 Nursing, Boston
Children's Hospital, Boston, MA; 2 Pediatric Stem Cell
Transplant, Dana Farber Cancer Institute, Boston, MA;
3 Pediatric Oncology, Dana Farber Cancer Instituite/Children's
Hospital Boston, Boston, MA; 4 Pediatric Stem Cell Transplant,
Dana-Farber Cancer Institute
The landscape of healthcare is changing as healthcare
providers continue to be faced with providing proﬁcient care
to complex patients as well as meeting standards and
requirements established and endorsed by federal agencies,
insurance companies and our patients. Hospitals are striving
to ensure they create an environment that promotes safety,
accessibility, efﬁciency, affordability and overall cost-effec-
tiveness. Leaders in healthcare are challenged to look for
innovative and efﬁcient ways to provide this care. The
manufacturing industry has effectively used Lean and Six
Sigma methodologies as the backbone of their quality
improvement initiatives. They have a slight different
approach but combined can be effective tools to be used for
problem solving, developing rapid improvement cycles,
lowering costs and increasing productivity. Lean methods
attempt to eliminate non-value added waste in a process
with the goal of improving performance and lowering costs.
Six Sigma is an approach that uses mathematic techniques to
reduce process variation. In today’s healthcare environment
it would be prudent to look at other industries for new
methods to improve processes that affect patient and staff
safety, workﬂow, costs and overall efﬁciencies. At Dana-
Farber Children’s Hospital Cancer Center within the Hema-
topoietic Stem Cell Transplant program there has been
signiﬁcant increase in the patient volume. This increase has
placed new demands on the multidisciplinary staff and
contributed to delays in workﬂow particularly with chemo-
therapy ordering and communication breakdowns. With the
increase in patient volume it became apparent that in order
to increase efﬁciency, the admission process needed to be
evaluated; fromwhen the patient is identiﬁed as a candidate
for a stem cell transplant to their admission to the inpatient
unit. Using the Lean and Six Sigma methodology and
applying it to the typical autologous, allogeneic related and
allogeneic unrelated transplant referrals we identiﬁed 125
process steps and 66 gaps in our admission processes. These
gaps are areas of potential risks. A risk priority matrix was
used to prioritize areas of improvement and the most
important 5 issues were then categorized into common
themes, which are related to institutional information
systems, multiple ways for patient referral and dissemina-
tion of internal information. Small workgroups are being
formed to address the issues. The potential impact on
medical care, cost savings and improved information ﬂow
will be demonstrated in this presentation as well as potential
for adapting Lean and Six Sigma methodology to other
medical academic institutions.
